Skip to content

Effects of preoperative dexmedetomidine nasal spray on postoperative fatigue syndrome in patients undergoing laparoscopic radical resection of colorectal cancer: a randomized controlled trial

Effects of preoperative dexmedetomidine nasal spray on postoperative fatigue syndrome in patients undergoing laparoscopic radical resection of colorectal cancer: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400095019
Enrollment
Unknown
Registered
2024-12-31
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative fatigue syndrome

Interventions

Dexmedetomidine Group:Before patients fall asleep, dexmedetomidine will be sprayed into the nasal cavity, 1 spray on each nostril and stayed for 30s, and then 1 spray on each nostril for a total of 4
Saline Group:Before patients fall asleep, normal saline will be sprayed into the nasal cavity, 1 spray on each nostril stayed for 30s, and then 1 spray on each nostril for a total of 4 sprays, and the

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Ages greater than or equal to 18 years old; 2. Scheduled for elective laparoscopic radical resection of colorectal cancer under general anesthesia; 3. ASA grades I-III.

Exclusion criteria

Exclusion criteria: 1. History of radiotherapy or chemotherapy for colorectal cancer; 2. Communication barriers or an inability to understand the scales involved in this study; 3. History of upper respiratory tract infection in the last 15 days; 4. Preoperative left ventricular ejection fraction <40%, second degree or greater atrioventricular block, pathological sinus syndrome, or preoperative heart rate less than 50 beats/min; 5. History of severe cardiovascular or cerebrovascular disease; 6. History of severe liver or kidney insufficiency; 7. Moderate to severe anemia or coagulopathy; 8. History of neurological, vascular, or musculoskeletal disorders; 9. Allergic to dexmedetomidine; 10. Patients with the preoperative Christensen score of 6 or more; 11. Refusal to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative fatigue syndrome;

Secondary

MeasureTime frame
The duration and severity of postoperative fatigue;Changes in fatigue scores;Sleep quality ;Postoperative pain scores;Time to first press of patient-controlled analgesia;Number of presses for patient-controlled analgesia;Number of patients received remedial analgesia;Total amount of postoperative analgesic drugs;Consumption of intraoperative anesthetic drugs;Intraoperative hemodynamics;The consumption of intraoperative vasoactive drugs;Inflammatory markers;Postoperative recovery quality;Time to first flatus and defecation;The incidence of adverse events;The degree of patients' satisfaction during hospitalization;Length of hospital stay;Time to extubation;Sedation scores after intervention;athens insomnia scale scores;

Countries

China

Contacts

Public ContactSu Liu

The Affiliated Hospital of Xuzhou Medical University

liusu_xzmu@163.com+86 181 1830 9692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026